Search for: "J" Results 1081 - 1100 of 124,224
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Sep 2022, 6:14 pm by Howard Bashman
“Why Lawyers Love Jackpot Talc Litigation: The bankruptcy code helps claimants and J&J — but not the tort bar. [read post]
16 Jun 2020, 10:40 am by Robert J. Fleming
The suit alleges that J&J, along with such other suppliers and distributors of talcum powder as Gold Bond and Shower to Shower and private label brands from CVS, Dollar General, Target (a Dayton Hudson company), Walgreens and Walmart–were hiding that their talc products contained dangerous and potential deadly toxins that caused cancer, reproductive issue and birth defects. [read post]
11 Jan 2012, 11:28 am by info@thomasjhenrylaw.com
The FDA claims that J&J’s Animas unit sold faulty insulin pumps and failed to disclose information about serious injuries in consumers using the defective devices. [read post]
26 Mar 2018, 8:59 am by Geoffrey G. Gussis, Esq.
J&J, which is headquartered in New Brunswick, would make the business incubator part of its JLabs, a collection of eight incubators across the U.S., Europe and Asia. [read post]
16 Mar 2015, 4:21 pm by Patrick
The post Teen Injured in School Bus Accident on SE J Street in Bentonville, Arkansas appeared first on Injury Accident News and Opinions. [read post]
15 Apr 2018, 4:31 pm by Stephen Bilkis
Matter of B. v J. 2018, NY Slip Op. 02148 L.B., Petitioner, Respondent. [read post]
5 Oct 2009, 7:12 am
Flying J receives the credits as a result of improvements made to its oil refinery located in Bakersfield, California. [read post]
20 Jul 2012, 11:52 am by Brenda Fulmer
Janssen, DePuy, Ethicon, and Gynecare are some of the divisions of J & J that have overseen dangerous and defective product recalls. [read post]
1 Oct 2017, 10:45 am by Doyle, Barlow & Mazard PLLC
(“Integra”) and Johnson & Johnson (“J&J”) agreed to a divestiture of five neurosurgical medical device product lines to settle FTC allegations that Integra’s proposed $1 billion acquisition of J&J’s Codman Neuro division (“Codman”) would negatively impact competition in those markets. [read post]